Cargando…

The Use of an Interleukin-6 Inhibitor in Vasoplegic Shock from Severe Systemic Inflammatory Response Syndrome: A Case Report

A 66-year-old Caucasian male with a history of chronic myelomonocytic leukemia (CMML) developed fluid-unresponsive hypotension requiring initiation of four different maximum dosed vasopressors, steroids, and broad-spectrum antibiotics 4 hours following four-vessel coronary artery bypass grafting inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elkhatib, Wiaam Y, Saunders, Hollie, Helgeson, Scott A, Moss, John E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559756/ https://www.ncbi.nlm.nih.gov/pubmed/34733038 http://dx.doi.org/10.5005/jp-journals-10071-23943

Ejemplares similares

Definitions and pathophysiology of vasoplegic shock
por: Lambden, Simon, et al.
Publicado: (2018)

Impact of concomitant gastroesophageal reflux disease symptomology on prognosis and pulmonary function of chronic hypersensitivity pneumonitis
por: Elkhatib, Wiaam Y., et al.
Publicado: (2023)

Vasopressin in vasoplegic shock: A systematic review
por: Webb, Andrew J, et al.
Publicado: (2020)

Extended Duration Infusion of Hydroxocobalamin for Vasoplegic Rescue in Septic Shock
por: Gerdes, Harrison J, et al.
Publicado: (2021)

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)

Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock
por: Ranzani, Otavio Tavares, et al.
Publicado: (2013)

Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report
por: Workum, Jessica D., et al.
Publicado: (2023)

Stratifying septic patients using lactate: severe sepsis and cryptic, vasoplegic and dysoxic shock profile
por: Ranzani, Otavio T, et al.
Publicado: (2013)

Vasopressin in vasoplegic shock in surgical patients: systematic review and meta-analysis
por: Szeles, Taís Felix, et al.
Publicado: (2023)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018)

Vasoplegic syndrome in patients undergoing heart transplantation
por: Qin, Tong-xin, et al.
Publicado: (2023)

Vasoplegic Syndrome and Anaesthesia: A Narrative Review
por: Gökdemir, Begüm Nemika, et al.
Publicado: (2023)

Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2009)

The Efficacy of Albumin Dialysis in the Reversal of Refractory Vasoplegic Shock Due to Amlodipine Toxicity
por: Connor-Schuler, Randi L., et al.
Publicado: (2020)

Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
por: Jimenez, J, et al.
Publicado: (2007)

Reply to: Complexities of Characterizing Vasoplegics
por: Magoon, Rohan, et al.
Publicado: (2023)

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis
por: Lim, Pascal, et al.
Publicado: (2022)

Acute pancreatitis and vasoplegic shock associated with leptospirosis – a case report and review of the literature
por: Maier, Alexander, et al.
Publicado: (2019)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
por: Ayers, Brian, et al.
Publicado: (2020)

Multisystem inflammatory syndrome in an adult with severe hypoxaemia and thyroiditis responsive to corticosteroid and interleukin 6 inhibitor treatment
por: Rojnukoolwanich, Thitirat, et al.
Publicado: (2022)

Very High Dose Epinephrine for the Treatment of Vasoplegic Syndrome during Liver Transplantation
por: Khosravi, M. B., et al.
Publicado: (2013)

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015)

High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm
por: Cheungpasitporn, Wisit, et al.
Publicado: (2017)

Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
por: Busse, Laurence W., et al.
Publicado: (2020)

Comment on “Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options”
por: Ortoleva, Jamel, et al.
Publicado: (2020)

Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
por: Ltaief, Zied, et al.
Publicado: (2022)

Positive fluid balance as a risk factor for mortality and acute kidney injury in vasoplegic shock after cardiac surgery
por: Rezende, A, et al.
Publicado: (2015)

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017)

Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review
por: Mirhosseini, Seyed Mohsen, et al.
Publicado: (2017)

Vasoplegic Syndrome Post-cardiopulmonary Bypass in a Renal Transplant Patient: The Brain Is Not the Index Organ
por: Bennett, Sean R, et al.
Publicado: (2022)

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
por: Peyko, Vincent, et al.
Publicado: (2021)

Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome: A Case Series
por: Konkol, Samuel B., et al.
Publicado: (2022)

Vasoplegic syndrome in cardiac surgery: role of synergism between polymorphism of tumor necrosis factor beta and plasminogen activator inhibitor type 1
por: Iribarren, JL, et al.
Publicado: (2015)

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)

Comparing Diagnosis and Treatment of Pulmonary Hypertension Patients at a Pulmonary Hypertension Center versus Community Centers
por: Saunders, Hollie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5spca2cvtbi8s4qttnaok686fu